GB1520247A - Pelletised medicament formulations - Google Patents

Pelletised medicament formulations

Info

Publication number
GB1520247A
GB1520247A GB35334/74A GB3533474A GB1520247A GB 1520247 A GB1520247 A GB 1520247A GB 35334/74 A GB35334/74 A GB 35334/74A GB 3533474 A GB3533474 A GB 3533474A GB 1520247 A GB1520247 A GB 1520247A
Authority
GB
United Kingdom
Prior art keywords
agglomerates
microns
medicament
pelletised
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35334/74A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10376566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB1520247(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB35334/74A priority Critical patent/GB1520247A/en
Priority to IE1645/75A priority patent/IE41586B1/en
Priority to ZA00754765A priority patent/ZA754765B/xx
Priority to CY1049A priority patent/CY1049A/xx
Priority to IL47829A priority patent/IL47829A/xx
Priority to CA232,477A priority patent/CA1072569A/en
Priority to NLAANVRAGE7509080,A priority patent/NL177980C/xx
Priority to AR259849A priority patent/AR210997A1/es
Priority to BE158922A priority patent/BE832097A/xx
Priority to FI752232A priority patent/FI65547C/fi
Priority to DE2535258A priority patent/DE2535258C2/de
Priority to BR7505055*A priority patent/BR7505055A/pt
Priority to FR7524631A priority patent/FR2282259A1/fr
Priority to DK360875A priority patent/DK145654C/da
Priority to SE7508967A priority patent/SE440595B/xx
Priority to LU73182A priority patent/LU73182A1/xx
Priority to NO752786A priority patent/NO146660C/no
Priority to HU75FI596A priority patent/HU175594B/hu
Priority to ES440139A priority patent/ES440139A1/es
Priority to JP50096732A priority patent/JPS5910326B2/ja
Priority to AU83859/75A priority patent/AU492916B2/en
Priority to DE19772702504 priority patent/DE2702504A1/de
Publication of GB1520247A publication Critical patent/GB1520247A/en
Priority to KE3034A priority patent/KE3034A/xx
Priority to HK177/80A priority patent/HK17780A/xx
Priority to MY34/81A priority patent/MY8100034A/xx
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
GB35334/74A 1974-08-10 1974-08-10 Pelletised medicament formulations Expired GB1520247A (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GB35334/74A GB1520247A (en) 1974-08-10 1974-08-10 Pelletised medicament formulations
IE1645/75A IE41586B1 (en) 1974-08-10 1975-07-23 Pelletised medicament formulations
ZA00754765A ZA754765B (en) 1974-08-10 1975-07-23 Pharmaceutical composition in pellet form
CY1049A CY1049A (en) 1974-08-10 1975-07-24 Pelletised medicament formulations
IL47829A IL47829A (en) 1974-08-10 1975-07-28 Medicament in pellet form and its preparation
CA232,477A CA1072569A (en) 1974-08-10 1975-07-29 Pellet form medicament
NLAANVRAGE7509080,A NL177980C (nl) 1974-08-10 1975-07-30 Werkwijze voor het vervaardigen van een vast, inhaleerbaar geneesmiddel-preparaat, alsmede houder, die een dergelijk preparaat bevat.
AR259849A AR210997A1 (es) 1974-08-10 1975-07-31 Metodo para la produccion del medicamento cromoglicato disodico en forma de granulos.
BE158922A BE832097A (fr) 1974-08-10 1975-08-04 Medicaments en granules friables propres a l'inhalation
FI752232A FI65547C (fi) 1974-08-10 1975-08-06 Foerfarande foer framstaellning av foer inhalering avsedda mjuka dinatriumkromoglykatpelletar
DE2535258A DE2535258C2 (de) 1974-08-10 1975-08-07 Inhalierbares Medikament in Pelletform
BR7505055*A BR7505055A (pt) 1974-08-10 1975-08-07 Medicamento em pelota e processo de sua manufatura
FR7524631A FR2282259A1 (fr) 1974-08-10 1975-08-07 Medicament sous forme de grains friables
DK360875A DK145654C (da) 1974-08-10 1975-08-08 Inhaleringspraeparat til anvendelse i en insufflator og fremgangsmaade til fremstilling deraf
SE7508967A SE440595B (sv) 1974-08-10 1975-08-08 Forfaraande for framstellning av mjuka dinatriumkromoglykatpelletkulor for inhalering
ES440139A ES440139A1 (es) 1974-08-10 1975-08-08 Metodo mejorado para la fabricacion de un medicamento de inhalacion en forma de granulos blandos.
LU73182A LU73182A1 (enrdf_load_stackoverflow) 1974-08-10 1975-08-08
NO752786A NO146660C (no) 1974-08-10 1975-08-08 Fremgangsmaate til fremstilling av myke dinatriumchromoglykatpellets.
HU75FI596A HU175594B (hu) 1974-08-10 1975-08-08 Sposob poluchenija farmacevticheskikh preparatov formulirovannykh v forme piljulej
JP50096732A JPS5910326B2 (ja) 1974-08-10 1975-08-11 軟質ペレツト状薬物の製造方法
AU83859/75A AU492916B2 (en) 1974-08-10 1975-08-11 Medicament in soft pellet form
DE19772702504 DE2702504A1 (de) 1974-08-10 1977-01-21 Arzneimittel in weicher tabletten- oder koernerform
KE3034A KE3034A (en) 1974-08-10 1980-03-10 Pelletised medicament formulations
HK177/80A HK17780A (en) 1974-08-10 1980-04-03 Pelletised medicament formulations
MY34/81A MY8100034A (en) 1974-08-10 1981-12-30 Pelletised medicament formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB35334/74A GB1520247A (en) 1974-08-10 1974-08-10 Pelletised medicament formulations

Publications (1)

Publication Number Publication Date
GB1520247A true GB1520247A (en) 1978-08-02

Family

ID=10376566

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35334/74A Expired GB1520247A (en) 1974-08-10 1974-08-10 Pelletised medicament formulations

Country Status (21)

Country Link
JP (1) JPS5910326B2 (enrdf_load_stackoverflow)
AR (1) AR210997A1 (enrdf_load_stackoverflow)
BE (1) BE832097A (enrdf_load_stackoverflow)
BR (1) BR7505055A (enrdf_load_stackoverflow)
CA (1) CA1072569A (enrdf_load_stackoverflow)
CY (1) CY1049A (enrdf_load_stackoverflow)
DK (1) DK145654C (enrdf_load_stackoverflow)
FI (1) FI65547C (enrdf_load_stackoverflow)
FR (1) FR2282259A1 (enrdf_load_stackoverflow)
GB (1) GB1520247A (enrdf_load_stackoverflow)
HK (1) HK17780A (enrdf_load_stackoverflow)
HU (1) HU175594B (enrdf_load_stackoverflow)
IE (1) IE41586B1 (enrdf_load_stackoverflow)
IL (1) IL47829A (enrdf_load_stackoverflow)
KE (1) KE3034A (enrdf_load_stackoverflow)
LU (1) LU73182A1 (enrdf_load_stackoverflow)
MY (1) MY8100034A (enrdf_load_stackoverflow)
NL (1) NL177980C (enrdf_load_stackoverflow)
NO (1) NO146660C (enrdf_load_stackoverflow)
SE (1) SE440595B (enrdf_load_stackoverflow)
ZA (1) ZA754765B (enrdf_load_stackoverflow)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0398631A1 (en) * 1989-05-17 1990-11-22 FISONS plc Pharmaceutical composition
GB2237510A (en) * 1989-11-04 1991-05-08 Danbiosyst Uk Small particle drug compositions for nasal administration
US5198221A (en) * 1989-05-17 1993-03-30 Fisons Plc Pharmaceutical composition
US5551489A (en) * 1993-10-01 1996-09-03 Astra Aktiebolag Agglomeration of finely divided powders
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6284287B1 (en) 1994-07-16 2001-09-04 Asta Medica Ag Particulate formulation for administration by inhalation
US6371171B1 (en) 1993-10-01 2002-04-16 Astra Aktiebolag Agglomeration of finely divided powders
US6436902B1 (en) 1994-12-22 2002-08-20 Astrazeneca Ab Therapeutic preparations for inhalation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6610653B1 (en) 1994-06-23 2003-08-26 Astrazeneca Ab Therapeutic preparation for inhalation
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6846801B1 (en) 1993-06-24 2005-01-25 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6884794B2 (en) 2000-04-17 2005-04-26 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
US7399528B2 (en) 1999-07-16 2008-07-15 Chiesi Farmaceutici S.P.A. Powder particles with smooth surface for use in inhalation therapy
EP2036544A1 (en) 1997-03-20 2009-03-18 Schering Corporation Dosage form of powder agglomerates
US8871274B2 (en) 2000-04-17 2014-10-28 Vectura Limited Pharmaceutical formulations for dry powder inhalers

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2741202A1 (de) * 1976-09-23 1978-03-30 Fisons Ltd Dinatriumcromoglycat mit besonderer massendichte
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1812574A1 (de) * 1968-12-04 1970-06-11 Riedel De Haen Ag Verfahren zur Herstellung biozider Granulate
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198221A (en) * 1989-05-17 1993-03-30 Fisons Plc Pharmaceutical composition
EP0398631A1 (en) * 1989-05-17 1990-11-22 FISONS plc Pharmaceutical composition
GB2237510A (en) * 1989-11-04 1991-05-08 Danbiosyst Uk Small particle drug compositions for nasal administration
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US6846801B1 (en) 1993-06-24 2005-01-25 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5551489A (en) * 1993-10-01 1996-09-03 Astra Aktiebolag Agglomeration of finely divided powders
US6371171B1 (en) 1993-10-01 2002-04-16 Astra Aktiebolag Agglomeration of finely divided powders
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
US6610653B1 (en) 1994-06-23 2003-08-26 Astrazeneca Ab Therapeutic preparation for inhalation
US6284287B1 (en) 1994-07-16 2001-09-04 Asta Medica Ag Particulate formulation for administration by inhalation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
US6436902B1 (en) 1994-12-22 2002-08-20 Astrazeneca Ab Therapeutic preparations for inhalation
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
EP2036544A1 (en) 1997-03-20 2009-03-18 Schering Corporation Dosage form of powder agglomerates
US8173172B2 (en) 1997-03-20 2012-05-08 Schering Corporation Preparation of powder agglomerates
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7399528B2 (en) 1999-07-16 2008-07-15 Chiesi Farmaceutici S.P.A. Powder particles with smooth surface for use in inhalation therapy
US6884794B2 (en) 2000-04-17 2005-04-26 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
EP1719505A2 (en) 2000-04-17 2006-11-08 CHIESI FARMACEUTICI S.p.A. Pharmaceutical formulations for dry powder inhalers in the form of hard pellets
US7223748B2 (en) 2000-04-17 2007-05-29 Chiesi Farmaceutici S.P.A. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
EP2272508A2 (en) 2000-04-17 2011-01-12 Vectura Limited Pharmaceutical Formulations for Dry Powder Inhalers
US8871274B2 (en) 2000-04-17 2014-10-28 Vectura Limited Pharmaceutical formulations for dry powder inhalers
US9566239B2 (en) 2000-04-17 2017-02-14 Vectura Limited Pharmaceutical formulations for dry powder inhalers

Also Published As

Publication number Publication date
BE832097A (fr) 1976-02-04
BR7505055A (pt) 1976-08-03
IL47829A (en) 1978-01-31
JPS5910326B2 (ja) 1984-03-08
KE3034A (en) 1980-03-28
FI752232A7 (enrdf_load_stackoverflow) 1976-02-11
IL47829A0 (en) 1975-10-15
IE41586L (en) 1976-02-10
FI65547B (fi) 1984-02-29
FI65547C (fi) 1984-06-11
NL177980C (nl) 1986-01-02
NO752786L (enrdf_load_stackoverflow) 1976-02-11
SE7508967L (sv) 1976-02-11
LU73182A1 (enrdf_load_stackoverflow) 1976-08-13
HK17780A (en) 1980-04-11
MY8100034A (en) 1981-12-31
CA1072569A (en) 1980-02-26
FR2282259B1 (enrdf_load_stackoverflow) 1978-11-03
DK145654C (da) 1983-08-15
NL7509080A (nl) 1976-02-12
DK145654B (da) 1983-01-17
SE440595B (sv) 1985-08-12
FR2282259A1 (fr) 1976-03-19
NO146660C (no) 1982-11-17
NO146660B (no) 1982-08-09
HU175594B (hu) 1980-09-28
JPS5144625A (enrdf_load_stackoverflow) 1976-04-16
CY1049A (en) 1980-08-01
DK360875A (da) 1976-02-11
AU8385975A (en) 1977-02-24
AR210997A1 (es) 1977-10-14
IE41586B1 (en) 1980-02-13
ZA754765B (en) 1976-07-28
NL177980B (nl) 1985-08-01

Similar Documents

Publication Publication Date Title
GB1520247A (en) Pelletised medicament formulations
FR2304359A1 (fr) Dispositif pour rechauffer et humidifier l'air respire par un patient, par exemple dans le cas d'une respiration artificielle
ATE206046T1 (de) Inhalationspräparate
CA2050298A1 (en) Dry powder inhalation device
CA2014640A1 (en) Auxiliary device for use with aerosol container
RU97102349A (ru) Композиция для получения лекарственного средства (варианты) и способ ее получения
ATE164060T1 (de) Inhalationspulver und verfahren zu ihrer herstellung
CA2195065A1 (en) Inhalation composition
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
GB9606677D0 (en) Process and device
EP0951917A3 (en) Particle delivery of particularly a powdered therapeutical agent
CA1338978C (en) Compositions and methods for manufacturing medicaments in compressed powders
EP0023359A3 (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa, and method for administration thereof
EP1310268A3 (en) Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values
GB1381872A (en) Pharmaceutical compositions for inhalation
EP0022662A3 (en) A cosmetic breath freshener and palate coolant composition and method of use
ES8608490A1 (es) Procedimiento de obtencion de una preparacion farmaceutica en forma de liberacion lenta y que comprende pinacidil (n'-ciano-n-4-piridil-n'-1, 2, 2-trimetil-propilguanidina), opcionalmente junto con otros componentes
JPS57135801A (en) Hydrophilic latex particles, manufacture and diagnostic drug containing same
IE45260L (en) Particulate medicament
JPS61217153A (ja) 義歯固定用糊剤
US4676973A (en) Method for diagnosing lung abnormalities using radiolabelled agents
DE3583991D1 (de) Arzneimittel enthaltend einen aus den peyer'schen plaques hergestellten organextrakt zur behandlung bei diabetes mellitus und pankreatitis.
GB1520248A (en) Sodium cromoglycate containing medicament
Nouvet et al. Respiratory Signs of Flax Strippers.
Gibb et al. Deposition of a Radioactive Aerosol in Excised Guinea Pig Lungs

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19950723